Myriad Genetics, Inc. · NASDAQ:MYGN
State Street Corp reported a 6.40% stake in Myriad Genetics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 6.40% stake in Myriad Genetics, Inc., 5,966,567 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 5,966,567
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 6.40% | 5,966,567 |
Source
Related
- Myriad Genetics, Inc.
- State Street Corp
- Myriad Genetics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · May 12, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026